• Home
  • News and Events

News and events

  • Email
  • Help

This section of the website contains the European Medicines Agency's news and press releases, information on meetings and events, public consultations and related information.

For a scrolling feed of all of the new and updated information published on the website, see the what's new page.

Latest news

This month's events

December 2017

1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31
  • 2017-12-14 - 2017-12-14 : EMA

    Meeting with Alliance for Regenerative Medicine

    This meeting was organised at the request of the Alliance for Regenerative Medicines organisation (AMR). The purpose of the meeting was to gain insight into and understanding of the role and responsibilities of the European Medicines Agency and to discuss areas of common interest.

  • 2017-12-14 - 2017-12-15 : CHMP

    Workshop on site and histology - Independent indications in oncology

    Biological drivers that define cancer course across anatomical sites and histologies offer an opportunity to select populations sensitive to specific drugs based on those drivers, independently of the specific site or histology. This workshop aims to provide an exchange of views from different stakeholders about situations where a site and histology-independent clinical development might be a viable option and the associated challenges in terms of drug development, benefit-risk evaluation and health-technology assessment.

  • 2017-12-13 - 2017-12-14 : MB

    Management Board meeting: 13-14 December 2017

    The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency’s performance.

  • 2017-12-12 - 2017-12-15 : PDCO

    Paediatric Committee (PDCO): 12-15 December 2017

    The Paediatric Committee (PDCO) is the committee that is responsible for assessing the content of paediatric investigation plans, which describe how a medicine should be studied in children, as well as waivers and deferrals.

  • 2017-12-11 - 2017-12-14 : CHMP

    Committee for Medicinal Products for Human Use (CHMP): 11-14 December 2017

    The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.